-
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Recommendation of "Buy" by Analysts
Source: Buzz FX / 23 Dec 2024 03:02:12 America/New_York
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Recommendation of "Buy" by Analysts Written by MarketBeat December 23, 2024 Share Link copied to clipboard. Cullinan Therapeutics, Inc. ( NASDAQ:CGEM - Get Free Report ) has been given
Read more...